Industry Satellite Symposia

CONSENSUS OR CONTROVERSY? - Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Patients with Locally Advanced Non-Small Cell Lung Cancer

Sunday, September 15
6:00 PM - 8:00 PM
Location: Hyatt Regency McCormick Place, Regency Ballroom CDE

6:00 p.m. – 6:30 p.m. Registration
6:30 p.m. – 8:00 p.m. Symposium
Hyatt Regency McCormick Place, Regency Ballroom CDE
Dinner will be provided.

Accreditation: Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credits: Research To Practice designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience: This activity is intended for radiation oncologists, medical oncologists, fellows in these fields, and other healthcare professionals involved in the management of patients with lung cancer.

Learning Objectives:


Assets

CONSENSUS OR CONTROVERSY? - Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Patients with Locally Advanced Non-Small Cell Lung Cancer



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for CONSENSUS OR CONTROVERSY? - Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Patients with Locally Advanced Non-Small Cell Lung Cancer